University of Texas Southwestern Medical Center
1,181
184
242
633
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
19.7%
233 terminated/withdrawn out of 1181 trials
73.1%
-13.5% vs industry average
14%
171 trials in Phase 3/4
56%
357 of 633 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1181)
Motor Network Physiology
Role: lead
Walk Together Efficacy Trial
Role: lead
Enfortumab Vedotin and Stereotactic Radiation for Localized Bladder Cancer
Role: lead
Promoting Shared Decision Making for Severe Aortic Stenosis
Role: collaborator
Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury
Role: lead
Cholinergic Enhancement of Theta
Role: lead
Periprostatic Neurolysis in Prostate Cancer
Role: lead
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
Role: lead
TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
Role: lead
Assistive Devices and Gait in Persons With Ataxia
Role: lead
Tirzepatide for Obesity and Meth Use Disorder
Role: lead
Cool Prime Comparative Effectiveness Study for Mild HIE
Role: lead
National Liver Cancer Screening Trial
Role: lead
A Polypill for Acute Coronary Syndrome
Role: lead
Dystonia Genotype-Phenotype Correlation
Role: lead
A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer
Role: lead
Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
Role: lead
Non-Invasive Testing to Evaluate Wound Healing in Diabetes
Role: lead
Polypill in Acute Coronary Syndrome
Role: lead
Parent-Adolescent Relationships, Emotional Regulation, and HRV in Adolescents With Depression
Role: lead